Were You Diagnosed with Cancer After Using Metformin?

YOU MAY BE ELIGIBLE TO JOIN THE METFORMIN DRUG LAWSUIT. COMPLETE THE FORM BELOW FOR A FREE METFORMIN LAWSUIT EVALUATION.







    OUR METFORMIN LAWSUIT LAWYERS ARE CURRENTLY REVIEWING CLAIMS OF INDIVIDUALS WHO HAVE BEEN DIAGNOSED WITH CANCER AFTER TAKING METFORMIN

    UPDATE NOVEMBER 3rd, 2020:
    FDA Announces Additional Metformin Recalls

    The Food and Drug Administration recently announced the recall of two additional batches of Metformin.  The newest recalls are for Metformin HCI extended release tablets (USP 500 mg and USP 750 mg) manufactured by Nostrum Laboratories due to NDMA levels above the acceptable daily intake limit. Our Metformin Attorneys are following these recent developments and assisting potential clients with information gathering and evaluation for potential claims.

    In July of 2020, the FDA issued a recall of the diabetes medicine Metformin after determining that the medication may contain unsafe levels of N-Nitrosodimethylamine (NDMA). NDMA is a carcinogen that, when consumed in high enough doses, can cause cancer in humans. While trace levels of naturally-occurring NDMA is considered acceptable and safe for human consumption, excessive consumption can be catastrophic. Excessive and unsafe levels of NDMA led to the recall of Zantac back in the fall of 2019. Those exposed to excessive and unsafe levels of NDMA, such as those potentially found in Meformin ER (extended release) have been known to cause cancers in those exposed, typically in the gastrointestinal system including the colon, liver, uterus, rectum, stomach, kidney, esophagus, pancreatic, and bladder.

    METFORMIN RECALLS IN 2020 DUE TO REPORTED HIGH LEVELS OF CANCER-CAUSING NDMA CONTAMINATION

    November 2nd and 3rd, 2020FDA alert regarding the voluntary recall of extended release Metformin (Metformin ER) by:

    • Nostrum Laboratories, Inc. Metformin HCI extended release tablets (USP 500 mg and USP 750 mg);

    October 5th, 2020FDA alert regarding the voluntary recall of extended release Metformin (Metformin ER) by:

    • Marksans Pharma Metformin ER tablets labeled as Time-Cap Labs (500 mg and 750mg);
    • Sun Pharmaceutical Industries Metformin hydrochloride labeled as Riomet ER (500 mg per 5mL);

    August 21, 2020FDA alert regarding the voluntary recall of extended release Metformin (Metformin ER) by:

    • Bayshore Pharmaceuticals Metformin ER tablets (750 mg and 500 mg);

    July 13th, 2020FDA alert regarding the voluntary recall of extended release Metformin (Metformin ER) by:

    • Granules Pharmaceuticals;
    • Lupin Pharmaceuticals;
    • Avkare;
    • PD-Rx Pharmaceuticals repackaging for Amneal;
    • PD-Rx Pharmaceuticals repackaging for Marksans;
    • The Harvard Drug Company repackaging for Apotex;
    • Preferred Pharmaceuticals repackaging for Marksans;

    June 11th, 2020FDA alert regarding the voluntary recall of extended release Metformin (Metformin ER) by:

    • Apotex;
    • Anmeal;
    • Marksans;
    • Lupin;
    • Teva;
    If you or a loved one have been adversely affected after taking Metformin IR or Metformin ER,
    call the Metformin Lawyers at Marin and Barrett, Inc. today at (888) 348-2735 for a free,
    no obligation consultation. We can help with your Metformin lawsuit. You can also fill out our
    one-minute questionnaire below to find out whether you have a claim.
    Contact Us For A Metformin Case Evaluation

    Metformin Lawsuit Information

    WHAT IS METFORMIN (GLUMETZA, FORTAMET, AND GLUCOPHAGE XR)?

    Metformin, which is also sold under the trade names Glucophage, Fortamet, Glumetza, and Riomet, is part of the class of drugs called biguanides, which inhibit the production of glucose in the liver. The medicine does not increase insulin levels in the body, but instead lessens the amount of sugar the body produces and absorbs. As it lowers glucose production in the liver, metformin also lowers blood sugar by increasing the body’s sensitivity to insulin. It also decreases the amount of glucose that our bodies absorb from the foods we eat.

    The developments in modern medicine over the last decades have been nothing short of miraculous. Advancements in courses of treatment and the research and development of drugs have allowed millions of people to live with diseases and conditions that were once considered untreatable or incurable. While nobody could argue that these advances are a bad thing, not every advancement is a success. Sometimes the side effects of a drug are apparent at the beginning of the development or testing phase; these effects are either tweaked or fixed, or the development is scrapped altogether. However, in many cases the dangers of a drug are not apparent until much later, oftentimes years or even decades after a drug has been on the market. In many of these instances the Food and Drug Administration (FDA) will issue a warning to the public to alert us of the discovery of new and potentially dangerous side effects, as is the case with Xeljanz. In more severe cases the FDA will issue an out and out recall of the drug removing it from the market entirely, such as it did with Zantac and Valsartan.

    METFORMIN VOLUNTARILY RECALLED IN MAY 2020 – DOES METFORMIN CAUSE CANCER?

    In May of 2020, the FDA issued a recall of the diabetes medicine Metformin after determining that the medication may contain unsafe levels of N-Nitrosodimethylamine (NDMA). NDMA is a carcinogen that, when consumed in high enough doses, can cause cancer in humans. While trace levels of naturally-occurring NDMA is considered acceptable and safe for human consumption, excessive consumption can be catastrophic. Excessive and unsafe levels of NDMA led to the recall of Zantac back in the fall of 2019. Those exposed to excessive and unsafe levels of NDMA, such as those potentially found in Meformin ER (extended release) have been known to cause cancers in those exposed, typically in the gastrointestinal system including the colon, liver, uterus, rectum, stomach, kidney, esophagus, pancreatic, and bladder.

    Given that the recall is less than a month old, it is unlikely that those affected by contaminated lots of Metformin even know that they have been affected, or that those who have been diagnosed with cancer due to NDMA exposure have yet attributed it to the drug. But much as medical advances take time, so do advances in the legal system. With diabetes affecting so many people across the nation and the world it is likely only a matter of time before those harmed by Metformin ER come to the fore, at which point we can likely expect a groundswell of litigation nationwide.

    If you or a loved one has been diagnosed with cancer after using Metformin, you may be entitled to financial compensation. Call the Metformin lawyers at Marin and Barrett, Inc. today at (888) 348-2735. The call and consultation are free and confidential.

    CAN A METFORMIN ATTORNEY HELP ME WITH A LEGAL CLAIM IF I HAVE BEEN DIAGNOSED WITH CANCER?​

    If you or a loved one developed cancer after taking Metformin IR or Metformin ER you may have a claim. You may be entitled to financial compensation for damages, including:

    • Past, present, and future medical expenses
    • Lost wages and lost earning potential
    • Pain and suffering
    • Loss of consortium
    • Punitive damages, if appropriate

    In the tragic event that a loved one as died as a result of cancer caused by Metformin IR or Metformin ER, you may be eligible to file a wrongful death claim. Of course there is no amount of money that can bring them back or fill the void left by their absence, but a claim may cover funeral and burial expenses, pain and suffering, and any past expenses incurred as a result of their illness.

    METFORMIN LAWYERS: HOW CAN WE HELP YOU WITH YOUR METFORMIN CANCER LAWSUIT?​

    The Pharmaceutical Industry is an international financial powerhouse, spending $1.2 trillion worldwide and $485 billion in the United States alone in 2018. Do not go it alone, let us fight them for you to get the compensation you rightfully deserve. We work hand in hand with some of the most experienced and respected law firms nationwide and have the resources your case needs to stand toe to toe with pharmaceutical giants.

    • 1
    • 1
    • 1
    • 1
    • 1

    “Attorney Parrillo listened with compassion. He outlined and explained each step of the legal process in way that was easy to understand. He was very generous with his time and took a genuine interest in my case.”

    – Former Client M. B. –

    At Marin and Barrett, Inc. we firmly believe that the client’s needs come above all else and have established a fully transparent fee structure to reflect that. We work on a strictly contingency fee basis, meaning that we do not receive anything from you unless we are able to recover money either by settlement or verdict. Regardless of what type of case you have or what is required, you will know everything up front with no surprises. We shoulder the costs of the filing and litigation on your behalf and at no risk to you.

    Call our Metformin attorneys Marin and Barrett, Inc. today (888) 348-2735 to schedule your free consultation, it only takes a few moments and there is no obligation. You can also contact us by completing our one-minute Metformin questionnaire below.

    Contact Us For A Metformin Case Evaluation

    METFORMIN DISCLAIMER

    Disclaimer: Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Past results afford no guarantee of future results and each case is different and is judged on its own merits. Some cases result in no recovery. Costs and expenses will be advanced and reimbursed to us only if you recover. You have no liability for costs or expenses unless a court directs. The choice of a lawyer is an important decision and should not be based solely upon advertisements. Some matters may be referred to other lawyers. From Marin and Barrett’s offices in Rhode Island the firm has represented clients from all parts of Rhode Island, Connecticut, and Massachusetts and has partnered with other law firms to serve clients throughout the U.S.

    ATTORNEY MATTHEW MARIN*

    *Admitted in Rhode Island, Connecticut, Massachusetts and South Carolina​
    ​Assisting clients as a Rhode Island Metformin Lawyer, Connecticut Metformin Lawyer, and a Massachusetts Metformin Lawyer

    ATTORNEY KENSLEY BARETT**

    >
    **Admitted in Rhode Island
    ​Assisting clients as a Rhode Island Metformin Lawyer

    ATTORNEY NICHOLAS PARRILLO***

    ***Admitted in Rhode Island and Massachusetts
    Assisting clients as a Rhode Island Metformin Lawyer and a Massachusetts Metformin Lawyer